Actos

Lea en español

Pioglitazone, a prescription drug sold under the trade name Actos, is a pharmaceutical product proven to lower blood sugar levels in persons with Type 2 diabetes. It has also been used in experiments to treat persons with fatty liver.
In 2007, the manufacturer of the drug, Takeda Pharmaceutical Company, acknowledged that Pioglitazone had been tied to increased risk of bone fracture in females. Studies also show that Actos can cause fluid retention and risk of peripheral edema, may hasten the development of congestive heart failure, and may cause anemia. Users have also experienced weight gain, respiratory tract infections, headaches and sinus conditions, and toothaches.
In 2011, officials in France took Pioglitazone off the market because of concerns that there was a high risk of bladder cancer associated with the drug. The U.S. Food and Drug Administration (FDA) warned users that same year that use of Pioglitazone for more than one year could increase risk of bladder cancer.
If you or someone you love has suffered injury after taking Actos, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.

Defective Drugs & Medical Devices Topics

Latest Articles

Divorce and Taxes

  If you are facing a divorce, you know that there are plenty of difficult, even painful questi…

07 Dec 2018, Friday

Legalizing Recreational Marijuana: A New State Revolution?

  Election night 2018 brought about several changes in the legal landscape, but probably none s…

06 Dec 2018, Thursday

The State(s) of Medicaid Expansion

  In 2012, the Patient Protection and Affordable Care Act (“ACA”) made some sweeping chang…

05 Dec 2018, Wednesday